AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution

AMPLY Discovery applies AI to identify and validate new oncology drug targets. It combines computational analysis with laboratory testing to generate therapeutic programmes for partnering.